A fourth dose of mRNA COVID-19 vaccine boosted antibodies among half of kidney transplant recipients with suboptimal immune responses after three doses, a French case series found. ...
... as daily infections break records and hospitals across the country near capacity during the Omicron surge, many people have raised questions about whether they'll need to get a fourth dose.
Dr. Catherine Smallwood, Covid-19 incident manager at the WHO Health Emergencies Programme, told a virtual WHO Europe news conference Tuesday that Covid-19 is “still a way off” endemicity.
As health care workers prepare to enter the third year of the pandemic, we are experiencing disillusionment and burnout on an extraordinary scale. Many of us have confronted more death and sickness than ever before in our careers.
As a physician at a teaching hospital that was one of the hardest hit in New York, I have witnessed firsthand the mayhem that this pandemic has brought on. Some of my colleagues harbor frustration and even anger at patients who have chosen to remain unvaccinated or not wear masks and now are hospitalized with Covid-19, imposing additional risks to us and our families.
At-home rapid antigen tests are reselling for triple the retail price on some digital marketplaces. Testing locations in L.A. County have been overwhelmed by mile-long lines, with some events canceled due to traffic. Some would-be self-testers have resigned themselves to driving between CVS and Walgreens locations, hoping to snag a kit at a reasonable price.
Companies are racing to fulfill the excess demand.
Abbott Laboratories, which makes the BinaxNOW rapid antigen test, expects to produce 70 million tests this month and is working to raise that to 100 million, said CEO Robert Ford.
Recent Comments